Wantstats
Company ProfilePremium

Olympus Corporation

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Olympus Corporation - Healthcare showcase

Year Founded & Workforce

1919

46,500 Employees

Industry

Healthcare

Services

Vocal Cord
O

Olympus Corporation Employee Contacts

85 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Olympus Corporation Overview

Company Headquarters: Japan

Founded: 1919

Workforce: 46,500

Company Working: Olympus Corporation is a Japanese multinational corporation that specializes in manufacturing and selling optical and reprography products, as well as medical and surgical equipment. The company was founded in 1919 and is headquartered in Tokyo, Japan. Olympus Corporation is organized into four main business segments: Medical, Scientific Solutions, Imaging, and Financial. The Medical segment is the largest and most important business segment of the company, accounting for approximately two-thirds of the company's total revenue. The Medical segment includes endoscopy and surgical products, as well as clinical and research microscopes which includes Biopsy devices.

Within the Medical segment, Olympus Corporation offers a range of products for minimally invasive surgical procedures, including endoscopes and endotherapy devices. One of the key products offered by Olympus Corporation is its biopsy device, which is used to collect tissue samples from various parts of the body for diagnostic purposes. Olympus Corporation's biopsy device is designed to be used with endoscopes and comes in a range of sizes and shapes to suit different clinical needs. The company has a global presence with operations in various regions around the world. The company's headquarters is located in Tokyo, Japan, and it has several subsidiaries and offices in different countries.

Strategy

Olympus Corporation is a global technology leader in the medical, scientific, and industrial markets. The company's key strategy is to leverage its advanced technology and strong brand recognition to drive growth through a combination of product innovation, strategic partnerships, and business restructuring. Olympus invests heavily in research and development to create new and innovative products that meet the evolving needs of its customers, while also pursuing strategic partnerships to expand its product offerings and market reach. The company also aims to enhance its operational efficiency and profitability through business restructuring and cost-cutting measures. By executing on these strategic initiatives, Olympus seeks to maintain its competitive edge, enhance customer satisfaction, and deliver sustainable long-term value to its stakeholders.

Company Snapshot

$7,314M

Revenue

46,500

Employees

1919

Founded

Japan

Headquarters

SWOT Analysis

Strengths

  • Strong global presence
  • Strong workforce
  • Strong brand presence around the world of advertising media
  • Wide product portfolio
  • Huge workforce
  • Successful mergers & acquisitions
  • Strong R&D capabilities
  • Improving profitability
  • Strong liquidity
  • Strong research and development
  • Strong distribution network
  • Diversified business portfolio

Weaknesses

  • Legal issues and product recalls in past years can impact the company’s image
  • Unable to obtain the licenses and approvals in various countries
  • Civil litigation filed in the US
  • Product recall
  • Heavy reliance on the Medical segment for revenue

Opportunities

  • Opportunities to increase its market penetration in the healthcare sector
  • Increasing mergers and acquisitions
  • Strengthen corporate value
  • Growing demand of minimally invasive devices in healthcare sector
  • Focus on strategic partnership and alliance
  • New product launches
  • Growing global demand for medical and imaging equipment, particularly in emerging markets

Threats

  • Growing competition from global market players
  • Threat of substitution
  • Increase in counterfeit products
  • Stringent regulations
  • Intense competition
  • Intense Competition

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
May 2016Product LaunchOlympus launched an action camera Stylus TG-Tracker designed to work in any environment. The camera holds features such as waterproof, dustproof, shockproof, and freezeproof.
Sep-2021Product LaunchOlympus Corporation launched EZ Shot 3 Plus 25 G needle in September 2021. The EZ Shot 3 Plus is a fine needle biopsy device that is designed to obtain high-quality tissue samples with minimal damage to surrounding tissue.
Jan-2021Product LaunchOlympus Corporation has also been focused on improving the usability and efficiency of its biopsy devices. For example, in January 2021, the company launched its next-generation electrosurgical generator, the ESG-150, which features a range of advanced features to improve safety, performance, and ease of use during endoscopic procedures. The ESG-150 is compatible with a range of Olympus endoscopes and devices, including biopsy forceps and needles.
Oct-2020Product LaunchOlympus Corporation introduced its EndoJaw disposable biopsy forceps, which offer improved tissue acquisition and reduced contamination risk, as well as greater procedural efficiency and cost-effectiveness.
Oct-2020Product LaunchOlympus Corporation has been working on the development of robotic systems for endoscopic procedures, including biopsy procedures. In 2019, the company announced the launch of its ENDO-AID robotic system, which is designed to improve the accuracy and efficiency of endoscopic procedures, including biopsies.
Oct-2019PartnershipOlympus Corporation announced a partnership with AI software developer Ai4gi to develop a system for detecting and diagnosing gastrointestinal (GI) cancers using endoscopic images. The system uses Olympus' endoscopic imaging technology and Ai4gi's AI algorithms to analyze images in real-time and provide clinicians with real-time diagnostic support.

Product Offering

  • Olympus Corporation
    • Vocal Cord

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 6,389 Mn in 2015 to USD 7,109 Mn in 2017.
Olympus Corporation — By Business Segment
Series (USD Mn)201520162017
Sales6,3897,8727,109

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →